Zepbound reduced apnea effect by up to 63% and achieved about 20% weight loss after a year.
Eli Lilly reports positive data in Phase 3 trial of weight-loss drug as treatment for sleep apnea
Read Next
- Microsoft’s Recall photographic memory search has issues in test build
- Injective (INJ)Summit Highlights: A Glimpse into the Future of Finance
- NVIDIA Omniverse Enhances 3D Visual Marketing with Generative AI
- Quantoz Launches Euro and Dollar-Backed Stablecoins EURQ and USDQ
- People who prefer a more quiet and solitary life as they get older usually display these 7 behaviors
- Revolutionizing Ethereum: Addressing Fragmentation with Intent-Based Solutions
- LIC losses nearly Rs 9000 crore; PSBs witness fall, ET BFSI
